Whitehawk Therapeutics Statistics
Total Valuation
WHWK has a market cap or net worth of $67.84 million. The enterprise value is $21.43 million.
Important Dates
The next estimated earnings date is Thursday, May 15, 2025, before market open.
| Earnings Date | May 15, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
WHWK has 46.78 million shares outstanding. The number of shares has increased by 0.42% in one year.
| Current Share Class | 46.78M |
| Shares Outstanding | 46.78M |
| Shares Change (YoY) | +0.42% |
| Shares Change (QoQ) | +0.17% |
| Owned by Insiders (%) | 7.91% |
| Owned by Institutions (%) | 29.48% |
| Float | 36.20M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.51 |
| Forward PS | n/a |
| PB Ratio | 0.68 |
| P/TBV Ratio | 1.29 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.82 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.59, with a Debt / Equity ratio of 0.02.
| Current Ratio | 3.59 |
| Quick Ratio | 3.11 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -420.91 |
Financial Efficiency
Return on equity (ROE) is -80.79% and return on invested capital (ROIC) is -50.71%.
| Return on Equity (ROE) | -80.79% |
| Return on Assets (ROA) | -39.96% |
| Return on Invested Capital (ROIC) | -50.71% |
| Return on Capital Employed (ROCE) | -121.74% |
| Revenue Per Employee | $649,575 |
| Profits Per Employee | -$1.59M |
| Employee Count | 40 |
| Asset Turnover | 0.26 |
| Inventory Turnover | 9.21 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -19.66% in the last 52 weeks. The beta is 0.49, so WHWK's price volatility has been lower than the market average.
| Beta (5Y) | 0.49 |
| 52-Week Price Change | -19.66% |
| 50-Day Moving Average | 2.02 |
| 200-Day Moving Average | 2.13 |
| Relative Strength Index (RSI) | 27.08 |
| Average Volume (20 Days) | 92,186 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, WHWK had revenue of $25.98 million and -$63.69 million in losses. Loss per share was -$2.36.
| Revenue | 25.98M |
| Gross Profit | -28.07M |
| Operating Income | -64.82M |
| Pretax Income | n/a |
| Net Income | -63.69M |
| EBITDA | -64.63M |
| EBIT | -64.82M |
| Loss Per Share | -$2.36 |
Full Income StatementBalance Sheet
The company has $47.24 million in cash and $833,000 in debt, giving a net cash position of $46.40 million or $0.99 per share.
| Cash & Cash Equivalents | 47.24M |
| Total Debt | 833,000 |
| Net Cash | 46.40M |
| Net Cash Per Share | $0.99 |
| Equity (Book Value) | 52.48M |
| Book Value Per Share | 2.13 |
| Working Capital | 44.21M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$59.55 million and capital expenditures -$1.65 million, giving a free cash flow of -$61.20 million.
| Operating Cash Flow | -59.55M |
| Capital Expenditures | -1.65M |
| Free Cash Flow | -61.20M |
| FCF Per Share | -$1.31 |
Full Cash Flow StatementMargins
Gross margin is -108.04%, with operating and profit margins of -249.47% and -245.13%.
| Gross Margin | -108.04% |
| Operating Margin | -249.47% |
| Pretax Margin | -245.13% |
| Profit Margin | -245.13% |
| EBITDA Margin | -248.73% |
| EBIT Margin | -249.47% |
| FCF Margin | n/a |